Pharmafile Logo

KOL Strategy

- PMLiVE

Gowrley quits MHP for role at Bupa

Agency head leaves less than one year after taken over from Mike Birtwistle

- PMLiVE

Pharma’s four options for innovation

Only genuinely creative companies will profit from the future

- PMLiVE

MHRA received 286 advertising complaints in 2013

UK medicines regulator publishes annual report

- PMLiVE

GSK takes drug hunter challenge into Europe

Invites academics to submit partnership proposals

- PMLiVE

NICE backs new use for Bayer’s Eylea

Will go up against Novartis’ Lucentis in treatment of macular oedema in UK

- PMLiVE

AZ gets limited approval for metreleptin in US

First FDA-backed treatment for rare disease lipodystrophy

- PMLiVE

GSK’s Lawson elected PAGB president

He will help lead OTC trade body after departure of Novartis' David Barnett

- PMLiVE

Serviceplan ranks top among German creative agencies

Beats Peix Healthcare Communications and Schmittgall in magazine ranking

- PMLiVE

Biosimilars: friend or foe for healthcare systems?

An opportunity in Europe, but widespread acceptance and uptake is by no means a done deal

- PMLiVE

WCCT Global talks up orphan drug benefits of new service

CRO's In-Site programme will harness digital technology for patient recruitment

- PMLiVE

INC Research appoints Jane Winter

She will lead the CRO's global consulting practice

Medpace acquired by private equity firm for $915m

The CRO will continue to be led by founder and CEO Dr August Troendle

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links